Pharmac issue RFP for immunotherapy
We are pleased to finally see a RFP for lung cancer immunotherapy issued.
When immunotherapy treatment is funded for stage four lung cancer (NSCLC), it will be life changing for approximately 26 patients every week..
The combined voice of; patients, carers, patients family’s, health care professionals, specialists, researchers, advocates and community has made this possible.
Much respect to the huge number of patients that have advocated for this day.
Sadly, many patients have passed, although their spirit is enduring. We will never forget them.
Newshub 6pm News Report